BioNTech
BNTX
BNTX
269 hedge funds and large institutions have $4.21B invested in BioNTech in 2026 Q1 according to their latest regulatory filings, with 42 funds opening new positions, 91 increasing their positions, 72 reducing their positions, and 51 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
8% less capital invested
Capital invested by funds: $4.56B → $4.21B (-$349M)
18% less first-time investments, than exits
New positions opened: 42 | Existing positions closed: 51
56% less call options, than puts
Call options by funds: $86.1M | Put options by funds: $198M
Holders
269
Holding in Top 10
4
Calls
$86.1M
Puts
$198M
Top Buyers
| 1 | +$141M | |
| 2 | +$68.9M | |
| 3 | +$54.8M | |
| 4 |
BlackRock
New York
|
+$51.9M |
| 5 |
First Trust Advisors
Wheaton,
Illinois
|
+$46.4M |
Top Sellers
| 1 | -$108M | |
| 2 | -$105M | |
| 3 | -$53M | |
| 4 |
Baillie Gifford & Co
Edinburgh,
United Kingdom
|
-$37.2M |
| 5 |
D.E. Shaw & Co
New York
|
-$29.7M |
